---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-064544"
form_type: "8-K"
ticker: "NNVC"
cik: "0001379006"
company_name: "NANOVIRICIDES, INC."
filed_at: "2026-05-20T20:30:33+00:00"
generated_at: "2026-05-20T20:34:15.602402+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# NanoViricides raises $2M in registered direct offering of shares and warrants

## Summary
- Offering of 1,333,334 shares (or pre-funded warrants) plus 1,333,334 warrants at $1.75, priced at $1.50 per share.
- Gross proceeds $2,000,001; closed May 18, 2026; D. Boral Capital as placement agent.
- Single institutional investor purchased entire offering; CEO agreed to 30-day lock-up.
- Net proceeds to fund working capital, R&D, and clinical trial expenses.

## SEC filing metadata
- accession: 0001104659-26-064544
- form_type: 8-K
- ticker: NNVC
- cik: 0001379006
- company_name: NANOVIRICIDES, INC.
- filed_at: 2026-05-20T20:30:33+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1379006/000110465926064544/0001104659-26-064544-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1379006/000110465926064544/tm2615013d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-064544
- JSON: https://secwatch.observer/filing/0001104659-26-064544.json
- Plain text: https://secwatch.observer/filing/0001104659-26-064544.txt

## Key facts
- Material Agreements
  NANOVIRICIDES, INC. entered into Placement Agency Agreement with D. Boral Capital LLC (the "Placement Agent") (effective 2026-05-15).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: D. Boral Capital LLC (the "Placement Agent")
  - Effective: 2026-05-15
  source text: the Company entered into a Placement Agency Agreement with D. Boral Capital LLC (the "Placement Agent"), dated May 15, 2026, pursuant to which the Placement Agent acted as the exclusive placement agent for the Company in connection with the Offering (the "Placement Agency Agreement")
  evidence_url: https://www.sec.gov/Archives/edgar/data/1379006/000110465926064544/0001104659-26-064544-index.htm
- Material Agreements
  NANOVIRICIDES, INC. entered into Securities Purchase Agreement with a certain purchaser (the "Investor") valued at approximately $2.0 million (effective 2026-05-15).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: a certain purchaser (the "Investor")
  - Value: approximately $2.0 million
  - Effective: 2026-05-15
  source text: On May 15, 2026, NanoViricides, Inc. (the "Company") and a certain purchaser (the "Investor") entered into a securities purchase agreement (the "Securities Purchase Agreement")
  evidence_url: https://www.sec.gov/Archives/edgar/data/1379006/000110465926064544/0001104659-26-064544-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.